[SLRX] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
27-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 54.77%
YoY- -57.90%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,443 -3,877 -5,341 -6,371 -14,409 -4,718 -6,109 -45.69%
Tax -89 -120 -80 111 -78 -38 -14 242.78%
NP -2,443 -3,877 -5,261 -6,482 -14,331 -4,718 -6,095 -45.60%
Tax Rate - - - - - - - -
Total Cost 2,443 3,877 5,261 6,482 14,331 4,718 6,095 -45.60%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.65 -1.43 -2.20 -2.88 -6.38 -2.20 -3.29 -66.04%
EPS Diluted -0.65 -1.43 -2.20 -2.88 -6.38 -2.20 -3.29 -66.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.